| Tag | Content |
|---|
EnhancerAtlas ID | HS130-05968 |
Organism | Homo sapiens |
Tissue/cell | MDA-MB-231 |
Coordinate | chr11:116818500-116820200 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| BCL6 | MA0463.2 | chr11:116818615-116818631 | TATCTTTCTAGGAATT | + | 6 | | TFAP2C | MA0524.2 | chr11:116820140-116820152 | TGCCCTGGGGCA | + | 6.44 | | TFAP2C | MA0524.2 | chr11:116820140-116820152 | TGCCCTGGGGCA | - | 7.22 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_03873 | chr11:116819647-116821101 | Brain_Anterior_Caudate | | SE_09356 | chr11:116818720-116821531 | CD14 | | SE_10994 | chr11:116818603-116822140 | CD20 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 3 | Chromosome | Start | End |
| chr11 | 116819179 | 116819356 | | chr11 | 116819758 | 116819875 | | chr11 | 116819899 | 116820185 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH11I116948 | chr11 | 116818917 | 116819916 |
|
Enhancer Sequence | TCATCTCCTG ACCTCGTGAT CTGCCCACCT CAGCCTCCCA AAGTGCTGGG ATTACAGGCA 60
TGAGCCACCG TGCCTGGCCT CTATTTCTTC TTAAGTCAGT TGTTTCAACA GTTGGTATCT 120
TTCTAGGAAT TTGTCCATTT CATCTAAGCT GACTTTTTTT TTTTTTTTGA GACAGGGTCT 180
CACTCTGTTG CCCAGACTGG AGTGCAGTGG TGCAATCATA GCTCACTGCA ACCTCCACCT 240
CCTAGGCTCA GGTGATCCTC CCACTTCAGC CTCTCGAGTA GCTGGGACTA CAGGTGTGCA 300
CCACCATGCA TGGCTAATTT TTCTATTTTT TTTTGTAGAG ATGGTGTTTC ACCATGTTGC 360
CCAGGCTGGT CTTGAACTCC TGAGGTCAAG CAATCCACTC ACCTCAGCCC CCCAAAGTGC 420
TAGGATTATA GGCATGAGCC ACCAAGCCCA GCTGATTTGT TGATGTATAG TTGTTCATAA 480
TATTCCTTTA TAATCATTTT TATTTTTTTT TAAGACAGGG TCTTGCTCTG TTGCCCAGGC 540
TGAAATGCAT TGGCACAATC ATGGCTCACT GCAGCCTTGA CATCCTGGGC TCAAGTGATC 600
CTCCTGCCTC AGCCTCCTAA GTAGCTGGGA CCACAGGCTC ATGCTACCAC ATCCGGCTAA 660
TTTTTTATGT TTAGTAGAAA TGAGGTCTCA CTATGTTGTC CATGCTGGTA CTGAACTCCT 720
GGGCTAAAGC AATCCTCCCA CCTCAGCATA CCAAAGTGCT GGGATTATAG GCGTGAGTCA 780
CCATGCCCAG CCCATTTTTG TTTCTTAAGG GACTGTAGTA ATGTTCCTTT CTTTCACTTC 840
TGATTCTAGT CATTTCAGTC TTCTCTTTTT CTCTTCTCTC TCTCGTCAAT CTAGCTAAAG 900
ATCTGTCAAT GTTGTCGATT TTTTCAAAGA ACTATCTTTT GGTTTCACTG ATATCCTCTA 960
TTGTTTTTCT ATTCTCTATT TCATAATTTC TGCTATAATC TTTATTTCCT TCTTTCTGCT 1020
TGGCTTCAAG ACACTAGAAG AGGAAGAACA AACTAAAACT GAAGCAAGCA GAAAGAAGGA 1080
AATAACAAAT ATTATAGCAG AAATTATGAA ATAGAGGATA GAAAAACAAC CAACTATAAT 1140
GGAATGAAAT TGGAAATCAA GAGTAGGAAA CATTCGGGAA ATTCACAAAT ATGTGAAAAT 1200
TAAACAACAC ACTAATAAAT AAATAATGAA ACAAGACATC AAAAGTGAAT TCAGAAAATA 1260
CTTTCAAATG AATGAAAATG AAAATACGGC ATACTAAAAC TCATGATATG CAGCCAAAGC 1320
ATGCTTAGAG AGAAATTTAT AGCTGTAAAA TGCCCACAGT TAGAAAGATC TCGTATCAAT 1380
AACCTAAGGA GCTATGACTA CAGGCGCATG CCACCATGCC CAGCTAAAAG CTAGATTCTT 1440
CTAGTGAAGT TTATTTCTCC ATATTTACAG TGTTCAGCCT CTAATGTGAT TCCTCTGGAA 1500
CAGGCAGCTT CGGTATGCCT ACAGTTAGTT ACCTTGGGAT CACAGTGTTT TTGCTAGGAC 1560
TTTCTTCCTC TCATTTACTG ACCATACTCA GCCGTTAAAC TCCACTAGTT GCTGGCTGAT 1620
TGCCCTTTTG TTTTGAATAA TGCCCTGGGG CACAAATTGG TCTACAAACA ATACAATCAA 1680
ATTCTGGTTC CTTTGAAGAA 1700
|
